E V Gushanskaya Selected Research

COVID-19

1/2022	[Clinical aspects of the use of imidazopyridine derivatives in the treatment of sleep disorders associated with post-COVID syndrome].
1/2021	[Astenic disorders within the framework of post-covid syndrome].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

E V Gushanskaya Research Topics

Disease

2	COVID-19 01/2022 - 01/2021
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2024
1	Sleep Wake Disorders 01/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022
1	Cognitive Dysfunction 01/2018
1	Asthenia 01/2015
1	Schizophrenia (Dementia Praecox) 01/2015
1	Anxiety Disorders (Anxiety Disorder) 01/2015
1	Somatoform Disorders (Somatoform Disorder) 01/2015

Drug/Important Bio-Agent (IBA)

2	Anti-Anxiety Agents (Anxiolytics)IBA 01/2021 - 01/2015
1	Memantine (Namenda)FDA Link 01/2024
1	BenzodiazepinesIBA 01/2022
1	Zolpidem (Ambien)FDA LinkGeneric 01/2022
1	Hypnotics and Sedatives (Sedatives)IBA 01/2022
1	imidazopyridineIBA 01/2022
1	Pharmaceutical Sleep AidsIBA 01/2022
1	agomelatine (S20098)IBA 01/2018
1	Antidepressive Agents (Antidepressants)IBA 01/2018
1	gamma-Aminobutyric Acid (GABA)IBA 01/2015
1	Peptides (Polypeptides)IBA 01/2015
1	AcidsIBA 01/2015
1	Antipsychotic Agents (Antipsychotics)IBA 01/2015
1	TP 7IBA 01/2015
1	phenazepamIBA 01/2015
1	pantogab (hopantenic acid)IBA 01/2015

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2015